The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  66 (2024)
Volume  65 (2023)
Volume  64 (2022)
Volume  63 (2021)
Volume  62 (2020)
Volume  61 (2019)
Volume  60 (2018)
Volume  59 (2017)
Volume  58 (2016)
Volume  57 (2015)
Volume  56 (2014)
Volume  55 (2013)
Volume  54 (2012)
Volume  53 (2011)
Volume  52 (2010)
Related articles

VOLUME 64 , ISSUE 3 ( July-September, 2022 ) > List of Articles

Original Article

Interstitial Lung Disease in Rheumatoid Arthritis: A Prospective Study at a Tertiary Care Center

Jyotsna Oak, Satish Sharma, Rupali Shastri, Sunilkumar Singh

Keywords : High-resolution computed tomography, Interstitial lung disease, Nonspecific interstitial pneumonia, Rheumatoid arthritis, Spirometry, Usual interstitial pneumonia

Citation Information : Oak J, Sharma S, Shastri R, Singh S. Interstitial Lung Disease in Rheumatoid Arthritis: A Prospective Study at a Tertiary Care Center. Indian J Chest Dis Allied Sci 2022; 64 (3):168-172.

DOI: 10.5005/jp-journals-11007-0051

License: CC BY-NC 4.0

Published Online: 08-12-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Objective: The objective of this study was to evaluate the presence of interstitial lung disease (ILD) in rheumatoid arthritis (RA) and to determine the role of clinical, spirometry, and high-resolution computed tomography (HRCT) findings to facilitate early detection of ILD in RA. Materials and methods: This is a prospective study at a tertiary care hospital from February 2016 to June 2019. All patients satisfying the American College of Rheumatology (ACR) criteria for RA and having respiratory symptoms or signs were included. All patients had detailed history, clinical examination, laboratory evaluation, spirometry, and HRCT chest. Results: A total of 280 patients of RA with respiratory symptoms were evaluated, out of which 82 (29.29%) had pulmonary involvement. There were 70 women and 12 men. Rheumatoid factor was positive in 90.2% of patients while anti-CCP antibody was positive in 43.9%. Chest X-ray (CXR) showed bilateral haziness in 36.9%. HRCT findings revealed a usual interstitial pneumonia (UIP) pattern in 73.2% patients and 24% had an nonspecific interstitial pneumonia (NSIP) pattern. Spirometric evidence of lung involvement was present in 84.2% of these cases. 2D Echo showed pulmonary hypertension (PH) in 46.3% of patients. Conclusion: Screening for respiratory symptoms and signs is essential in the clinical evaluation of RA. CXR, HCRT chest, and spirometry can be used effectively to diagnose RA-ILD early.

HTML PDF Share
  1. Fabiana AF, Matteo P, Irene A, et al. Rheumatoid arthritis: Extra-articular manifestations and comorbidities. Autoimmunity Reviews. 2021;20(4):102776. https://doi.org/10.1016/j.autrev.2021.102776.
  2. Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 2010;62(6):1583–1591. PMID: 20155830.
  3. Lake F, Proudman S. Rheumatoid arthritis and lung disease: from mechanisms to a practical approach. Semin Respir Crit Care Med 2014;35(2):222–238. PMID: 24668537.
  4. Kay J, Upchurch KS. ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology 2012;(51):5–9. PMID: 23221588.
  5. Graham BL, Steenbruggen I, Miller MR, et al. Standardization of Spirometry Update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Resp Crit Care Med 2019;200:e70–88. DOI: 10.1164/rccm.201908-1590ST.
  6. England BR, Sayles H, Michaud K, et al. Chronic lung disease in US Veterans with rheumatoid arthritis and the impact on survival. Clin Rheumatol 2018;37(11):2907–2915. DOI: 10.1007/s10067-018-4314-9.
  7. Sparks JA, Chang SC, Liao KP, et al. Rheumatoid arthritis and mortality among women during 36 years of prospective follow-up: results from the Nurses’ Health Study. Arthritis care res 2016;68(6):753–762. PMID: 26473946.
  8. Kelly CA, Saravanan V, Nisar M, et al. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics—a large multicentre UK study. Rheumatology 2014; 53(9):1676–1682. DOI: 10.1093/rheumatology/keu165.
  9. Doyle TJ, Dellaripa PF, Batra K, et al. Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis. Chest 2014; 146(1):41–50. PMID: 24305643.
  10. Singh S, Collins BF, Sharma BB, et al. Interstitial lung disease in India. Results of a prospective registry. Am J Resp Crit Care Med 2017; 195(6):801–813. PMID: 27684041.
  11. Ellman P, Ball RE. “Rheumatoid disease” with joint and pulmonary manifestations. Br Med J 1948;2(4583):816. DOI: 10.1136/bmj.2.4583.816.
  12. Turesson C. Extra-articular rheumatoid arthritis. Curr Opin Rheumatol 2013;25(3):360–366. DOI: 10.1097/BOR.0b013e32835f693f.
  13. Huang S, Kronzer VL, Dellaripa PF, et al. Rheumatoid arthritis–associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatment. Curr Treatm Opt Rheumatol 2020;6(4):337–353. DOI: 10.1007/s40674-020-00160-z.
  14. Saag KG, Cerhan JR, Kolluri S, et al. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 1997;56(8):463–439. PMID: 9306868.
  15. Aubart F, Crestani B, Nicaise-Roland P, et al. High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis. J Rheumatol 2011; 38(6):979–982. DOI: 10.3899/jrheum.101261.
  16. Doyle TJ, Lee JS, Dellaripa PF, et al. A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease. Chest 2014;145(3):454–463. DOI: 10.1378/chest.13-2408.
  17. Gabbay E, Tarala R, Will R, et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Resp Crit Care Med 1997;156(2):528–535. PMID: 9279235.
  18. Pappas DA, Giles JT, Connors G, et al. Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study. Arthritis Res Ther 2010; 12(3):R104. DOI: 10.1186/ar3037.
  19. Habib HM, Eisa AA, Arafat WR, et al. Pulmonary involvement in early rheumatoid arthritis patients. Clin Rheumatol 2011;30(2):217–221. PMID: 20503061.
  20. Lee HK, Kim DS, Yoo B, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005; 127(6):2019–2027. DOI: 10.1378/chest.127.6.2019.
  21. de Lauretis A, Veeraraghavan S, Renzoni E. Review series: aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chron Respir Dis 2011;8(1):53–82. DOI: 10.1177/1479972310393758.
  22. Wolfe F, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti–tumor necrosis factor therapy. Arthritis Rheum 2006;54(2):628. PMID: 16447241.
  23. Cavagna L, Monti S, Grosso V, et al. The multifaceted aspects of interstitial lung disease in rheumatoid arthritis. Biomed Res Int 2013;759–760. DOI: 10.1155/2013/759760.
  24. Dawson JK, Fewins HE, Desmond J, et al. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 2001;56(8):622–627. DOI: 10.1136/thorax.56.8.622.
  25. Li L, Liu R, Zhang Y, et al. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol 2020;39:1457–1470. DOI: 10.1007/s10067-019-04846-1
  26. Zamora-Legoff JA, Krause ML, Crowson CS, et al. Progressive decline of lung function in rheumatoid arthritis–associated interstitial lung disease. Arthritis Rheumatol 2017;69(3):542–549. PMID: 27788297.
  27. Shahane A. Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis. Rheumatol Int 2013;33: 1655–1667.27. PMID: 23334373.
  28. Udayakumar N, Venkatesan S, Rajendiran C. Pulmonary hypertension in rheumatoid arthritis – relation with the duration of the disease. Int J Cardiol 2008;127:410–412. DOI: 10.1016/j.ijcard.2007.04.084.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.